Missing/wrong data?
Log in to edit
Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).
scientific article published on 17 October 2016
Author/s
author: Outi Kuittinen, Eila Sonkajärvi, Taina Turpeenniemi-Hujanen
Work details
Publication date
October 17, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.